Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysis.
<h4>Background</h4>Several studies have reported that metformin can reduce the risk of hepatocellular carcinoma (HCC) in diabetes patients. However, the direct anti-HCC effects of metformin have hardly been studied in patients, but have been extensively investigated in animal models of H...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0127967 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!